795 related articles for article (PubMed ID: 9397386)
21. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
Stuedal A; Ma H; Bjørndal H; Ursin G
Climacteric; 2009 Jun; 12(3):248-58. PubMed ID: 19387884
[TBL] [Abstract][Full Text] [Related]
22. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
23. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
Greenwald MW; Gluck OS; Lang E; Rakov V
Menopause; 2005; 12(6):741-8. PubMed ID: 16278618
[TBL] [Abstract][Full Text] [Related]
24. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG
Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442
[TBL] [Abstract][Full Text] [Related]
25. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
Yüksel H; Odabaşi AR; Demircan S; Karul A; Kozaci LD; Köseoğlu K; Kizilkaya K; Başak O
Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148
[TBL] [Abstract][Full Text] [Related]
26. Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in post-menopausal women evaluating three regimens of 17beta-estradiol and norethisterone when compared with an orally administered 17beta-estradiol norethisterone regimen.
Rozenberg S; Pornel B; Koninckx PR; Palacios S; Christiansen C
Hum Reprod; 2009 Jul; 24(7):1739-47. PubMed ID: 19351658
[TBL] [Abstract][Full Text] [Related]
27. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
28. Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study.
Samsioe G; Boschitsch E; Concin H; De Geyter C; Ehrenborg A; Heikkinen J; Hobson R; Arguinzoniz M; Ibarra de Palacios P; Scheurer C; Schmidt G;
Climacteric; 2006 Oct; 9(5):368-79. PubMed ID: 17080587
[TBL] [Abstract][Full Text] [Related]
29. Effects of oral continuous and transdermal cyclic 17-beta estradiol and norethindrone acetate replacement therapy on platelet aggregation in postmenopausal women.
Kaplan PB; Gücer F; Sayin NC; Yüce MA; Yardim T
J Reprod Med; 2002 Aug; 47(8):651-5. PubMed ID: 12216432
[TBL] [Abstract][Full Text] [Related]
30. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
31. Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density.
Lundström E; Bygdeson M; Svane G; Azavedo E; von Schoultz B
Climacteric; 2007 Jun; 10(3):249-56. PubMed ID: 17487652
[TBL] [Abstract][Full Text] [Related]
32. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
Ichikawa J; Sumino H; Ichikawa S; Ozaki M
Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
[TBL] [Abstract][Full Text] [Related]
33. The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women.
Cano A; Calaf J; Molina J
Arch Gynecol Obstet; 2003 Oct; 268(4):317-22. PubMed ID: 14504877
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study.
Kurtay G; Ozmen B
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):206-11. PubMed ID: 16814449
[TBL] [Abstract][Full Text] [Related]
35. [HRT in post-menopausal women: endometrial histology and bleeding patterns].
Lo Dico G; Alongi G; Spinelli MP; Cannariato P; Lucido AM
Minerva Ginecol; 2002 Aug; 54(4):361-6. PubMed ID: 12114870
[TBL] [Abstract][Full Text] [Related]
36. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC
Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
[TBL] [Abstract][Full Text] [Related]
37. Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.
Samsioe G; Hruska J;
Climacteric; 2010 Feb; 13(1):34-44. PubMed ID: 20001563
[TBL] [Abstract][Full Text] [Related]
38. Long-term transdermal estradiol therapy: effects on endometrial histology and bleeding patterns.
Clisham PR; Cedars MI; Greendale G; Fu YS; Gambone J; Judd HL
Obstet Gynecol; 1992 Feb; 79(2):196-201. PubMed ID: 1731285
[TBL] [Abstract][Full Text] [Related]
39. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
[TBL] [Abstract][Full Text] [Related]
40. Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women.
Brynhildsen J; Hammar M
Menopause; 2002; 9(2):137-44. PubMed ID: 11875333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
